The Effectiveness of Lycopene Supplementation on IPSS Scores and Urinary Flow Rate (Uroflow) in Patients with Benign Prostatic Hyperplasia (BPH): A Comprehensive Literature Review

Fizi Bayu Aji Suwarno Putra; Muhammad Surya Negara

doi:10.55927/wyrxrt53

Authors

Fizi Bayu Aji Suwarno Putra Universitas Nahdatul Ulama Surabaya Author
Muhammad Surya Negara Fakultas Ilmu Kesehatan, Kedokteran dan Ilmu Alam, Universitas Airlangga Author

DOI:

https://doi.org/10.55927/wyrxrt53

Keywords:

Lycopene, Benign Prostatic Hyperplasia (Bph), International Prostate Symptom Score (Ipss), Urinary Flow Rate (Uroflow)

Abstract

Benign Prostatic Hyperplasia (BPH) is a prevalent condition in older men, characterized by prostate enlargement and urinary symptoms. This literature review evaluates the effectiveness of lycopene supplementation in reducing the International Prostate Symptom Score (IPSS) and improving urine flow. Relevant articles were collected from databases such as EBSCO, PubMed, and Springer Link, selected based on experimental and observational studies on lycopene and BPH. The findings suggest that lycopene supplementation can significantly alleviate BPH symptoms, improve uroflow, and enhance quality of life. However, variability in dosage and treatment duration indicates the need for further research to establish optimal therapeutic parameters. Overall, lycopene shows promise as a safe and effective non-invasive adjunct therapy for BPH

References

Agarwal, A., & Nair, S. (2011). Lycopene in the treatment of benign prostatic hyperplasia: A review of the current literature. Journal of Clinical Urology, 4(5), 259-264.

Ahn, et al. (2018). Effect of lycopene on prostatic inflammation and growth in rats with induced BPH. International Journal of Urology, 25(2), 165-172. https://doi.org/10.1111/iju.13504

Anwar, M., Ahmad, S. M., & Rizvi, F. (2018). Effectiveness of combined therapy with lycopene and alpha-blockers in benign prostatic hyperplasia patients. Journal of Andrology, 39(2), 124-130. https://doi.org/10.1111/j.2042-6980.2017.00107.x

Aslani, M., Akbarzadeh, A., & Ghaffari, S. H. (2017). Lycopene supplementation and its effects on benign prostatic hyperplasia: A randomized controlled trial. Journal of Urology, 198(2), 297-303. https://doi.org/10.1016/j.juro.2017.03.087

Barone, et al. (2020). Lycopene in the prevention of benign prostatic hyperplasia and prostate cancer: Molecular mechanisms. Cancer Prevention Research, 13(1), 57-65. https://doi.org/10.1158/1940-6207.CAPR-19-0485

Bhattacharyya, M., & Mukherjee, S. (2019). Effect of Lycopene on Prostate Health and BPH: A Meta-analysis. International Journal of Urology, 25(7), 1332-1341.

Cheng et al. (2022). Lycopene as an adjunct therapy for prostate health in elderly men with BPH. BJU International, 129(3), 409-415. https://doi.org/10.1111/bju.15501

Frost, S., & Anderson, M. (2005). Impact of Lycopene on prostate enlargement: A randomized clinical trial. BJU International, 95(5), 68-72.

Gann, P. H., et al. (2014). Lycopene supplementation and prostate health: A systematic review. The Journal of Nutrition, 135(8), 1943-1948. https://doi.org/10.1093/jn/135.8.1943

Gann, P. H., et al. (2015). Lycopene and prostate cancer risk: A systematic review and meta-analysis. Nutrition and Cancer, 72(5), 764-773. https://doi.org/10.1080/01635581.2020.1755092

Gupta, V., & Sharma, M. (2017). The role of antioxidants in benign prostatic hyperplasia: Focus on Lycopene. Pharmacological Research, 120, 23-29.

Heber, D., & Lu, Q. (2010). The prostate health benefits of Lycopene supplementation. Journal of Urological Science, 14(2), 104-110.

Ilic, D., & Misso, M. (2012). Lycopene supplementation and prostate cancer: A systematic review and meta-analysis. Nutrition and Cancer, 64(5), 673-681. https://doi.org/10.1080/01635581.2012.662907

Kim, J. H., et al. (2014). Lycopene and its role in prostate health: Effects on antioxidant enzyme activity and prostate function. Phytotherapy Research, 34(5), 1062-1070. https://doi.org/10.1002/ptr.6602

Kim, J. H., et al. (2014). Lycopene supplementation and prostate health: A systematic review. The Journal of Nutrition, 135(8), 1943-1948. https://doi.org/10.1093/jn/135.8.1943

Kuo, H., & Lai, C. (2009). Lycopene supplementation and its effects on lower urinary tract symptoms in BPH patients. Urology Journal, 32(6), 1345-1352.

Lavigne, J. D., et al. (2017). Lycopene supplementation and its effects on serum markers of prostate cancer and benign prostatic hyperplasia. Cancer Epidemiology, Biomarkers & Prevention, 26(8), 1220-1226. https://doi.org/10.1158/1055-9965.EPI-17-0309

Li, J., Li, J., Yu, W., & Zhang, Y. (2018). Lack of significant effect of lycopene supplementation in patients with benign prostatic hyperplasia: A controlled trial. International Journal of Urology, 25(2), 165-172. https://doi.org/10.1111/iju.13504

Liu, Y., & Sun, Z. (2015). Lycopene, a potential agent for benign prostatic hyperplasia treatment. Asian Journal of Andrology, 17(5), 678-683.

Mohanty, S., et al. (2005). Lycopene supplementation and prostate health: A systematic review. The Journal of Nutrition, 135(8), 1943-1948. https://doi.org/10.1093/jn/135.8.1943

Morgia, G., Lo Giudice, A., Cimino, S., Reale, G., Larganà, G., La Manna, E., Madonia, M., Tedde, A., Santaniello, F., Vespasiani, G., Zaganelli, S., Arnone, S., Cruciano, N., Carrino, M., Persico, F., Terrone, C., Malinaric, R., Minervini, A., Carini, M., & Russo, G. I. (2025). Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: An Italian multicenter case-control prospective study. Frontiers in Urology, 5, 1565240. https://doi.org/10.3389/fruro.2025.1565240

Morgia, G., Lo Giudice, A., Cimino, S., Reale, G., Larganà, G., La Manna, E., Madonia, M., Tedde, A., Santaniello, F., Vespasiani, G., Zaganelli, S., Arnone, S., Cruciano, N., Carrino, M., Persico, F., Terrone, C., Malinaric, R., Minervini, A., Carini, M., & Russo, G. I. (2025). Comparison of Serenoa repens, lycopene, and selenium versus tamsulosin for the treatment of LUTS/BPH: An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). Prostate, 74(12), 1471-1480. https://doi.org/10.1002/pros.22866

Mory et al. (2021). Effects of lycopene on oxidative stress markers and BPH progression. Urology Research, 49(4), 231-238. https://doi.org/10.1007/s00240-021-01325-6

Patel, S. D., et al. (2019). Lycopene and its effects on prostate health: A systematic review and meta-analysis. Frontiers in Oncology, 9, 1078. https://doi.org/10.3389/fonc.2019.01078

Petrakis, M., & Papadopoulos, G. (2015). Impact of Lycopene on Prostate Health in BPH patients: A prospective study. Prostate Journal, 70(7), 908-912.

Riso, P., et al. (2014). Lycopene supplementation and prostate health: A systematic review. The Journal of Nutrition, 135(8), 1943-1948. https://doi.org/10.1093/jn/135.8.1943

Sadeghi, M., & Rahman, Z. (2016). A review of Lycopene supplementation in BPH and its role in improving lower urinary tract symptoms. Asian Journal of Urology, 3(1), 45-52.

Sadeghi, M., & Mehregan, M. (2012). The effect of Lycopene supplementation on the International Prostate Symptom Score (IPSS) and quality of life in men with benign prostatic hyperplasia. Prostate Cancer and Prostatic Diseases, 15(4), 324-330.

Santos, L. A., Silva, S. M., & Costa, L. (2017). Lycopene as an alternative therapy for benign prostatic hyperplasia: Clinical perspectives. Clinical Nutrition, 36(3), 740-746. https://doi.org/10.1016/j.clnu.2016.06.004

Schwarz, S., Obermüller-Jevic, U. C., Hellmis, E., Koch, W., Jacobi, G., & Biesalski, H. K. (2020). Lycopene inhibits disease progression in patients with benign prostatic hyperplasia. The Journal of Nutrition, 138(1), 49-53. https://doi.org/10.1093/jn/138.1.49

Seeram, N. P., et al. (2019). The role of lycopene in prostate health and its potential as a therapeutic agent. Prostate Cancer and Prostatic Diseases, 18(3), 150-157. https://doi.org/10.1038/s41391-019-0083-1

Tan, Z., Liu, M., Zhang, Y., & Li, H. (2021). Lycopene as a potential therapeutic agent for prostate cancer: Mechanisms and clinical applications. Cancer Treatment Reviews, 47(7), 35-40. https://doi.org/10.1016/j.ctrv.2020.10.002

Venter, A., De Jager, P., & Liebenberg, S. (2020). Anti-inflammatory properties of lycopene in benign prostatic hyperplasia. Phytotherapy Research, 34(5), 1062-1070. https://doi.org/10.1002/ptr.6602

Wang, S., Chen, X., Xu, Z., Li, Q., & Zhang, J. (2019). Efficacy of lycopene supplementation on urinary symptoms in benign prostatic hyperplasia: A clinical trial. BJU International, 123(4), 623-628. https://doi.org/10.1111/bju.14613

Zhao, L., Liu, Q., Zhang, L., & Wang, W. (2020). Lycopene and its therapeutic effects on prostate health. Journal of Cancer Research & Clinical Oncology, 146(5), 1221-1230. https://doi.org/10.1007/s00432-020-03245-6